eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine

HOME
QUERY
- DISEASE
- GENOTYPE
NETWORK
- PHENOTYPE
- GENE
- COMMON
- DISEASE PAIR
DOWNLOAD
SUBMIT CASE
HELP&FAQ
- HELP&FAQ
- CONTACT US

Disease	multiple endocrine neoplasia type 1
Comorbidity	C0024299\|lymphoma
Sentences	9
PubMedID- 23998543	Conclusions: the study indicated that cardiovascular mortality in lymphoma patients treated with (r)-chop regimen is relatively high and ecg monitoring may be the most effective in cardiological risk assessment.
PubMedID- 25286699	Objective: to compare the efficacy and safety of hypercvad regimen and chop regimen in treating patients with lymphoblastic lymphoma (lbl).
PubMedID- 23788991	Second malignancies after autologous haematopoietic stem cell transplantation following modified beam conditioning regimen in patients with hodgkin lymphoma - characteristics and risk factor analysis.
PubMedID- 20008638	The clinical impact of statin use on the outcome of lymphoma patients treated with a rituximab-containing regimen is unknown.
PubMedID- 25308760	Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed hodgkin lymphoma, ahod00p1: a children's oncology group report.
PubMedID- 24818119	[1] ileal intussusception caused by malt lymphoma as a cause of acute abdomen is extremely rare, with symptoms that often mislead and make diagnosis more difficult.
PubMedID- 25312719	Despite some limitations due to the retrospective nature of the study, palliative hrt for feline nts can be considered a useful treatment option because of the high incidence of improvement and more favourable prognosis, although it may be preferable not to use the hypofractionated regimen in young cats with lymphoma that are expected to survive for a long period.
PubMedID- 23136225	Introduction: to assess the efficacy of an abbreviated stanford v regimen in patients with early-stage hodgkin lymphoma (hl).
PubMedID- 23269584	This study was conducted to evaluate the efficacy and safety of gemcitabine-based combination regimen in patients with peripheral t-cell lymphoma (ptcl).

Page: 1